MapLight Therapeutics MPLT
NASDAQ MPLT
$8.24 +0.24 (+3.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

MapLight Therapeutics (MPLT) Research & Development (2024 - 2026)

Updated

MapLight Therapeutics' Research & Development came in at $53.44 million for Q2 2026, up 99.0% from $26.85 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) Research & Development (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, MapLight Therapeutics reported Research & Development of $172 million; for FY2025, it was $138.35 million, up 101.9% from FY2024.

  • Going back by year, Research & Development was $68.52 million in FY2024.
  • The five-year range for quarterly Research & Development is $16.81 million (Q3 2024) to $64.62 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 3.65 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 2.34 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 4.05 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 1.76 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 2.81 Bn
10 MapLight Therapeutics 374.35 Mn 374.35 Mn - 53.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53.44 Mn
Dec 31, 2025 64.62 Mn
Sep 30, 2025 27.09 Mn
Jun 30, 2025 26.85 Mn
Dec 31, 2024 20.71 Mn
Sep 30, 2024 16.81 Mn
API Access

MapLight Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=MPLT&period=max&api_key=YOUR_API_KEY